Organized by the Office of Science & Technology of the Embassy of France in the United States (Boston section), the French American Innovation Day (FAID) is designed to emphasize a specific topic that is significant to science, therapeutics and innovation. With the support of the Massachusetts Life Sciences Center (MLSC), the 2010 FAID seminar will address the latest research in Alzheimer's disease (AD) in France and the United States. WHY ADDRESS AD IN A BILATERAL JOIN EVENT?

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that currently affects millions of French and Americans.

A new report from the Alzheimer's Association shows that the number of Americans age 65 and older who have this condition will increase from the 5.1 million today to 13.5 million by mid-century.

Total costs of care for individuals with Alzheimer's disease by all payers will soar from $172 billion in 2010 to more than $1 trillion in 2050, with Medicare costs increasing more than 600 percent, from $88 billion today to $627 billion in 2050.


Attendance is free of charge but registration is required
Discover the benefits of becoming a sponsor for this unique seminar.